P11.01: Development and establishment of a national Danish fetal medicine database for quality surveillance and research

Abstract

Poster abstractswere rated to enable highly diagnostic confidence (82.9%), and produce better image quality for the near field image (94.3%), the far field image (88.6%), and overall (94.3%). Conclusions: The current study described an objective method of comparing image quality acquired using different sonographic technologies. Ultrasound transducer incorporated with PureWave Crystal technology produces significantly better image quality for diagnostic purpose.

Prenatal detection of congenital heart disease in a low risk population undergoing first and second trimester screening

“…Infants born with CHD, second trimester terminations due to CHD and second trimester intrauterine demise (miscarriages and stillbirths) with prenatally detected CHD in the period 01.01.2008–31.12.2010 were identified through the National Patient Registry and the Medical Birth Registry . Supplemental variables were extracted from the Danish Fetal Medicine Database, which contains background characteristics, data on ultrasound examinations in pregnancy and outcome for pregnancies . CHD was defined as congenital malformations of the heart chambers, heart valves, great arteries and septal defects, corresponding to diagnosis codes DQ20 to DQ25 in the International Classification of Disease‐10 classification system.…”

“…18 Supplemental variables were extracted from the Danish Fetal Medicine Database, which contains background characteristics, data on ultrasound examinations in pregnancy and outcome for pregnancies. 19 CHD was defined as congenital malformations of the heart chambers, heart valves, great arteries and septal defects, corresponding to diagnosis codes DQ20 to DQ25 in the International Classification of Disease-10 classification system.…”

Cuba’s Salgen: A Provincial Informatics Network for Genetic Services to Pregnant Women and Newborns

“…In Denmark, Ekelund reported the advantages of using databases. [24] Salgen's capability for data linkage with vital statistics provides an option-previously impractical-for research into antenatal and neonatal conditions and their relationships with individual and population health status.…”

Evaluation of Second-Trimester Maternal Serum AFP Value in the Detection of Congenital Heart Defects

“…Nuchal translucency (NT), which must be done between 11 and 14 weeks of pregnancy, significantly increased the diagnostic power of detecting CHE so that the power of simultaneous NT and echocardiography is up to 90% (9,10). However, echocardiography not only is difficult and expensive but also requires advanced equipment, which have translated into limited access to this service.…”